Gene · 3446
IFNA10: interferon alpha 10
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. IFNA10: interferon alpha 10. Genes, record 3446. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/3446
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P01566 | Interferon alpha-10 | 189 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents96
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| WO 2026164090 A | 2026-08-06 | 3 | P01566 | Espacenet |
| EP 4724500 A2 | 2026-04-15 | 424 | P01566 | Espacenet |
| EP 4705273 A2 | 2026-03-11 | 537 | P01566 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 10284 | P01566 | Espacenet |
| JP 2025169942 A | 2025-11-14 | 1091 | P01566 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 6726 | P01566 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 6647 | P01566 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 6647 | P01566 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 10284 | P01566 | Espacenet |
| JP 2025028160 A | 2025-02-28 | 6726 | P01566 | Espacenet |
1 to 10 of 96
See all 96 patentsDrugs2
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
Trials10
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
| Trial | Drug | Phase | Results first posted | Source |
|---|---|---|---|---|
| NCT01283139 | SIFALIMUMAB | PHASE2 | 2016-07-11 | ClinicalTrials.gov |
| NCT01031836 | SIFALIMUMAB | PHASE2 | 2018-11-19 | ClinicalTrials.gov |
| NCT00979654 | SIFALIMUMAB | PHASE2 | 2016-08-23 | ClinicalTrials.gov |
| NCT00962832 | RONTALIZUMAB | PHASE2 | ClinicalTrials.gov | |
| NCT00657189 | SIFALIMUMAB | PHASE2 | ClinicalTrials.gov | |
| NCT00541749 | RONTALIZUMAB | PHASE1 | ClinicalTrials.gov | |
| NCT00533091 | SIFALIMUMAB | PHASE1 | ClinicalTrials.gov | |
| NCT00482989 | SIFALIMUMAB | PHASE1 | ClinicalTrials.gov | |
| NCT00472758 | SIFALIMUMAB | PHASE1 | ClinicalTrials.gov | |
| NCT00299819 | SIFALIMUMAB | PHASE1 | ClinicalTrials.gov |
NIH grants317
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | IFNA10 papers | Newest fiscal year |
|---|---|---|---|
| UL1TR001866 | Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational Success | 5 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 3 | 2025 |
| R01AI163029 | Inborn errors of immunity in patients with life-threatening COVID-19 | 3 | 2025 |
| R01AR071384 | Characterization of interferon kappa as a novel target in cutaneous lupus | 3 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 2 | 2025 |
| P51OD011132 | Emory National Primate Research Center | 2 | 2025 |
| R01AI130025 | Role of the gender biased transcription factor VGLL3 in promoting autoimmune responses in SLE | 2 | 2025 |
| U19AI057229 | Understanding Influenza and SARS-CoV-2 vaccine responses, in vivo and in vitro | 2 | 2025 |
| ZIAAI000887 | Role of HIV Envelope Proteins In Viral Replication and HIV Pathogenesis | 2 | 2025 |
| I01CX002422 | Investigate the mechanism of autoreactive B cell-mediated immunological failure despite virologic suppression in HIV-infected individuals on antiretroviral therapy | 1 | 2025 |
1 to 10 of 317Source NIH's project files
See all 317 nih grantsPapers297
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Ferroptosis in Glioblastoma and Neuroblastoma: Molecular Mechanisms and Novel Therapeutic Strategies. | Curr Issues Mol Biol | 2026 | 41899419 | PubTator, text mining | PubMed |
| Essential role of hsa-miR-203a-3p in type I interferons immune homeostasis during influenza and NDV infection. | RNA Biol | 2026 | 41784292 | PubTator, text mining | PubMed |
| Fetal and Neonatal Immune Response to Congenital Cytomegalovirus (cCMV) Infection: A Systematically Conducted Scoping Review. | Viruses | 2026 | 41754585 | PubTator, text mining | PubMed |
| Elevated ferritin as a companion biomarker of myeloid-driven inflammation in RNP/Sm co-positive, treatment-resistant SLE endotype. | bioRxiv | 2026 | 41727036 | PubTator, text mining | PubMed |
| Somatic deficiency of the human E3 ubiquitin ligase CBL in leukocytes impairs B cell but not T cell development and function. | Nat Immunol | 2026 | 41540267 | PubTator, text mining | PubMed |
| Genetic Variants Specific to Critical COVID-19: Insights From Genome-Wide Association Studies and Structural Analysis. | J Med Virol | 2025 | 41268733 | PubTator, text mining | PubMed |
| Multimodal characterization of the responsiveness of eight hepatitis D virus genotype isolates to interferon-alpha treatment. | J Virol | 2025 | 40965142 | PubTator, text mining | PubMed |
| Rare genetic variants and severe COVID-19 in previously healthy admixed Latin American adults. | Sci Rep | 2025 | 40595275 | PubTator, text mining | PubMed |
| Rare Genetic Variants of NLRP12 in Admixed Latino-American Children With SARS-CoV-2-Related Multisystem Inflammatory Syndrome. | J Infect Dis | 2024 | 39328079 | PubTator, text mining | PubMed |
| Inhibition of SARS-CoV-2 infection and replication by Petasites hybridus CO2-extract (Ze 339). | Biomed Pharmacother | 2024 | 38061134 | PubTator, text mining | PubMed |
1 to 10 of 297
See all 297 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/3446
GET https://conductscience.org/api/genes/v1/3446/patents?page=2